N,N-dimethyl-2-[2-[1-[[2-[2-(4-methylanilino)-2-oxoethyl]sulfanylacetyl]amino]propyl]phenoxy]acetamide
C24H31N3O4S — CID 55902568
Data last refreshed: (MolForge compound catalog, from PubChem)
About N,N-dimethyl-2-[2-[1-[[2-[2-(4-methylanilino)-2-oxoethyl]sulfanylacetyl]amino]propyl]phenoxy]acetamide
N,N-dimethyl-2-[2-[1-[[2-[2-(4-methylanilino)-2-oxoethyl]sulfanylacetyl]amino]propyl]phenoxy]acetamide (PubChem CID 55902568) has the molecular formula C24H31N3O4S and a molecular weight of 457.60 g/mol. Its IUPAC name is N,N-dimethyl-2-[2-[1-[[2-[2-(4-methylanilino)-2-oxoethyl]sulfanylacetyl]amino]propyl]phenoxy]acetamide.
Molecular Properties
| Compound Name | N,N-dimethyl-2-[2-[1-[[2-[2-(4-methylanilino)-2-oxoethyl]sulfanylacetyl]amino]propyl]phenoxy]acetamide |
|---|---|
| PubChem CID | 55902568 |
| Molecular Formula | C24H31N3O4S |
| Molecular Weight | 457.60 g/mol |
| Exact Mass | 457.20 |
| IUPAC Name | N,N-dimethyl-2-[2-[1-[[2-[2-(4-methylanilino)-2-oxoethyl]sulfanylacetyl]amino]propyl]phenoxy]acetamide |
| SMILES | CCC(NC(=O)CSCC(=O)Nc1ccc(C)cc1)c1ccccc1OCC(=O)N(C)C |
| InChI | InChI=1S/C24H31N3O4S/c1-5-20(19-8-6-7-9-21(19)31-14-24(30)27(3)4)26-23(29)16-32-15-22(28)25-18-12-10-17(2)11-13-18/h6-13,20H,5,14-16H2,1-4H3,(H,25,28)(H,26,29) |
| InChIKey | BLCSUIQPKHHYGN-UHFFFAOYSA-N |
| XLogP | 3.40 |
| TPSA | 87.74 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 457.60 |
| LogP ≤ 5 | 3.40 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 55902568 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.